Lacking Evidence to Recommend Neoadjuvant Chemotherapy and Definitive Radiotherapy in Muscle-Invasive Bladder Cancer In response to: Trimodality Therapy for Muscle-Invasive Bladder Cancer: Recent Advances and Unanswered Questions published by Di Maria Jiang et al. Current Oncology Reports 2020, https://doi.org/10.1007/s11912-020-0880-5

We comment on the paper of Di Maria Jiang et al. published in Current Oncology Reports 2020, https://doi.org/10.1007/s11912-020-0880-5 . We disagree on a major recommendation of the authors because of lacking evidence. This response is considered to be important for readers of Current Oncology Repor...

Full description

Saved in:
Bibliographic Details
Published inCurrent oncology reports Vol. 23; no. 2; p. 18
Main Authors Böhmer, Dirk, Grün, Arne
Format Journal Article
LanguageEnglish
Published New York Springer US 01.02.2021
Subjects
Chemotherapy, Adjuvant
Cystectomy
Humans
Letter to the Editor
Medicine
Medicine & Public Health
Muscles
Neoadjuvant Therapy
Oncology
Urinary Bladder Neoplasms - drug therapy
Trimodality treatment
Neoadjuvant chemotherapy
Bladder cancer
Online AccessGet full text

Cover

More Information
Summary:We comment on the paper of Di Maria Jiang et al. published in Current Oncology Reports 2020, https://doi.org/10.1007/s11912-020-0880-5 . We disagree on a major recommendation of the authors because of lacking evidence. This response is considered to be important for readers of Current Oncology Reports.
Bibliography:SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Commentary-1
ObjectType-Review-2
ObjectType-Article-3
ISSN:1523-3790
1534-6269
DOI:10.1007/s11912-020-01012-8